Potential Protective Effects of Naloxone in Traumatic Brain Injury Through JAK2/STAT3 Signaling Modulation

Area of Science:

• Neuroscience
• Pharmacology
• Biomedical Research

Background:

• Traumatic brain injury (TBI) poses significant challenges in neuroprotection.
• Neuroinflammation and cognitive impairment are key pathological features of TBI.
• Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathways are implicated in TBI.

Purpose of the Study:

• To evaluate the neuroprotective potential of naloxone in a moderate TBI mouse model.
• To assess naloxone's effects on neuroinflammation, cognitive function, and JAK2/STAT3 signaling.
• To investigate naloxone's impact on specific molecular markers associated with TBI pathology.

Main Methods:

• Establishment of a moderate TBI model in male C57BL/6J mice using a stereotaxic impactor.
• Administration of naloxone (1 mg/kg/day) intraperitoneally for 7 days post-injury.
• Evaluation of immunohistochemical markers, cognitive functions (Y-maze, NOR test), brain swelling, and tissue loss.

Main Results:

• Naloxone treatment significantly reduced brain swelling and cortical tissue loss in TBI mice.
• Naloxone modulated inflammatory markers (reduced TGF-β2, increased IL-11) and oxidative stress (decreased ROS).
• Naloxone treatment improved cognitive performance in TBI mice and modulated JAK2/STAT3, Bcl-2, p53, Caspase 3, LC3B, and p62 expressions.

Conclusions:

• Naloxone exhibits significant neuroprotective effects in a mouse model of moderate TBI.
• Naloxone administration enhances cognitive performance following TBI.
• The neuroprotective mechanisms of naloxone may involve the modulation of JAK2/STAT3 signaling pathways.